COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

Dr. Kenneth Izumi

Dr. Kenneth Izumi

Scientific Review Officer


Division of Physiological and Pathological Sciences DPPS
Infectious Diseases and Microbiology IDM
Study Section:
Virology A VIRA

Dr. Kenneth Izumi is the Scientific Review Officer for CSR’s Virology A Study Section (VIRA).

He received his Ph.D. in microbiology and Immunology from UCLA, and his research on herpes simplex virus (HSV) focused on the genetics of viral neuroinvasiveness and role of the latency-associated transcripts (LATs) in viral pathogenesis. He received his postdoctoral training and became an instructor in microbiology and molecular genetics at Harvard Medical School. He then moved to the University of Texas Health Science Center San Antonio as an assistant professor of microbiology and immunology. He investigated the molecular mechanisms by which Epstein-Barr virus (EBV) latent infection membrane protein 1 (LMP1) contributes to the pathogenesis of EBV-related malignancies by altering the tumor necrosis factor receptor (TNFR) signaling pathway to regulate cell gene expression that enables latent EBV infected lymphocytes to proliferate.